Minerva Surgical (UTRS)
(Delayed Data from OTC)
$0.01 USD
0.00 (0.00%)
Updated Jun 25, 2024 02:55 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Minerva Surgical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 8 | 48 | 25 | -99,999 |
Receivables | NA | 7 | 7 | 8 | NA |
Notes Receivable | NA | 0 | 0 | 0 | NA |
Inventories | NA | 17 | 16 | 10 | NA |
Other Current Assets | NA | 4 | 4 | 2 | NA |
Total Current Assets | NA | 36 | 75 | 45 | NA |
Net Property & Equipment | NA | 5 | 5 | 3 | NA |
Investments & Advances | NA | 0 | 0 | 0 | NA |
Other Non-Current Assets | NA | 0 | 0 | 0 | NA |
Deferred Charges | NA | 0 | 0 | 0 | NA |
Intangibles | NA | 27 | 35 | 43 | NA |
Deposits & Other Assets | NA | 1 | 1 | 1 | NA |
Total Assets | NA | 69 | 115 | 92 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | NA |
Accounts Payable | NA | 3 | 4 | 4 | NA |
Current Portion Long-Term Debt | NA | 2 | 0 | 2 | NA |
Current Portion Capital Leases | NA | 0 | 0 | 0 | NA |
Accrued Expenses | NA | 9 | 14 | 13 | NA |
Income Taxes Payable | NA | 0 | 0 | 0 | NA |
Other Current Liabilities | NA | 0 | 5 | 15 | NA |
Total Current Liabilities | NA | 14 | 23 | 33 | NA |
Mortgages | NA | 0 | 0 | 0 | NA |
Deferred Taxes/Income | NA | 0 | 0 | 0 | NA |
Convertible Debt | NA | 0 | 0 | 66 | NA |
Long-Term Debt | NA | 37 | 39 | 29 | NA |
Non-Current Capital Leases | NA | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | NA | 0 | 9 | 62 | NA |
Minority Interest (Liabilities) | NA | 0 | 0 | 123 | NA |
Total Liabilities | NA | 52 | 71 | 314 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | NA |
Common Stock (Par) | NA | 0 | 0 | 0 | NA |
Capital Surplus | NA | 301 | 294 | 6 | NA |
Retained Earnings | NA | -284 | -250 | -228 | NA |
Other Equity | NA | 0 | 0 | 0 | NA |
Treasury Stock | NA | 0 | 0 | 0 | NA |
Total Shareholder's Equity | NA | 17 | 44 | -222 | NA |
Total Liabilities & Shareholder's Equity | NA | 69 | 115 | 92 | NA |
Total Common Equity | 0 | 17 | 44 | -222 | 0 |
Shares Outstanding | 8.80 | 1.40 | 1.40 | NA | NA |
Book Value Per Share | 0.00 | 12.27 | 31.50 | 0.00 | 0.00 |
Fiscal Year End for Minerva Surgical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,999 | 11 | 16 |
Receivables | NA | NA | NA | 8 | 8 |
Notes Receivable | NA | NA | NA | 0 | 0 |
Inventories | NA | NA | NA | 18 | 18 |
Other Current Assets | NA | NA | NA | 3 | 4 |
Total Current Assets | NA | NA | NA | 40 | 46 |
Net Property & Equipment | NA | NA | NA | 5 | 5 |
Investments & Advances | NA | NA | NA | 0 | 0 |
Other Non-Current Assets | NA | NA | NA | 0 | 0 |
Deferred Charges | NA | NA | NA | 0 | 0 |
Intangibles | NA | NA | NA | 22 | 23 |
Deposits & Other Assets | NA | NA | NA | 1 | 0 |
Total Assets | NA | NA | NA | 73 | 79 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 0 | 0 |
Accounts Payable | NA | NA | NA | 3 | 4 |
Current Portion Long-Term Debt | NA | NA | NA | 12 | 8 |
Current Portion Capital Leases | NA | NA | NA | 0 | 0 |
Accrued Expenses | NA | NA | NA | 6 | 5 |
Income Taxes Payable | NA | NA | NA | 0 | 0 |
Other Current Liabilities | NA | NA | NA | 0 | 0 |
Total Current Liabilities | NA | NA | NA | 21 | 18 |
Mortgages | NA | NA | NA | 0 | 0 |
Deferred Taxes/Income | NA | NA | NA | 0 | 0 |
Convertible Debt | NA | NA | NA | 0 | 0 |
Long-Term Debt | NA | NA | NA | 28 | 31 |
Non-Current Capital Leases | NA | NA | NA | 0 | 0 |
Other Non-Current Liabilities | NA | NA | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | 0 |
Total Liabilities | NA | NA | NA | 53 | 53 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | 0 |
Common Stock (Par) | NA | NA | NA | 0 | 0 |
Capital Surplus | NA | NA | NA | 331 | 330 |
Retained Earnings | NA | NA | NA | -311 | -304 |
Other Equity | NA | NA | NA | 0 | 0 |
Treasury Stock | NA | NA | NA | 0 | 0 |
Total Shareholder's Equity | NA | NA | NA | 20 | 27 |
Total Liabilities & Shareholder's Equity | NA | NA | NA | 73 | 79 |
Total Common Equity | 0 | 0 | 0 | 20 | 27 |
Shares Outstanding | 8.80 | 8.80 | 8.80 | 8.80 | 8.80 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 2.30 | 3.02 |